CompletedPhase 2NCT00903786

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Studying Arthrochalasia Ehlers-Danlos syndrome

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Eisai Co., Ltd.
Principal Investigator: Kazunori Saeki
Neuroscience Clinical Development Section. JAC PCU. Eisai Co., Ltd.
Intervention: perampanel(drug)
Enrollment: 21 enrolled
Eligibility: 20-64 years · All sexes
Timeline: 2009 – 2016

Study locations (9)

Kitakyushu, Fukuoka, Japan
Kobe, Hyōgo, Japan
Sendai, Miyagi, Japan
Komatsushimachō, Tokushima, Japan
Kodaira, Tokyo, Japan
Kyoto, Japan
Nagasaki, Japan
Niigata, Japan
Shizuoka, Japan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00903786 on ClinicalTrials.gov

Other trials for Arthrochalasia Ehlers-Danlos syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT07520877
Effect of AED-optimized Telephone-assisted CPR Instructions on No-flow Time and Chest Compression Fraction
University of Pecs

See all trials for Arthrochalasia Ehlers-Danlos syndrome →

← Back to all trials